Financials

News Discussions Technicals Forecast Seasonals

IMRX fundamentals

Overview Statements Statistics Dividends Earnings Revenue

The current financial position of Immuneering Corporation

Total assets of IMRX for Q2 24 is 77.09 M USD, 12.38% less than the previous Q1 24. And total liabilities increased by 16.43% in Q2 24 to 10.78 M USD.

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

‪0.00‬

Total assets

Total liabilities

Income statement Balance sheet Cash flow

Currency: USD

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

YoY growth

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—